Nu-Med Plus (NUMD) director reports no common stock held
Nu-Med Plus (NUMD) director Fred Tejada reported no direct ownership of common stock in a Form 3 filing. Tejada, also a SVP and Chief Geologist, is a 10% owner. The filing showed no buy or sell transactions.
How this was made
The 30-second read
Why it matters
The filing confirms the director holds no shares, providing no trading catalyst.
Market read
The filing adds a data point to the insider ownership record but offers no actionable market signal.
What to watch
Potential future purchases by the director are not indicated; the filing is purely informational.
Background
Form 3 is the initial insider ownership disclosure required when a director or officer becomes an insider.
Ticker impact
Form 3 filing discloses director Fred Tejada holds 0 shares of common stock, with no buy or sell activity.
None
The filing reports zero shares and no transactions, offering no actionable signal for traders.
Market effects
None
None
None
Counterpoint
Even a zero‑share filing could hint at future insider activity, but no evidence exists now.
Key entities
- individualFred Tejada
Director, SVP and Chief Geologist, ten‑percent owner reporting zero shares.
- companyNu-Med Plus, Inc.
Biopharmaceutical company filing the Form 3.

